B7Y Share Price Performance
€0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
Byotrol plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
B7Y Community Narratives
There are no narratives available yet.
Recent B7Y News & Updates
Byotrol plc Key Details
Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0041
- Gross Margin
- 42.51%
- Net Profit Margin
- -42.33%
- Debt/Equity Ratio
- 19.7%
Byotrol plc Competitors
Snowflake Analysis
About B7Y
- Founded
- 2005
- Employees
- 36
- CEO
- WebsiteView website
Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes. The company also offers HLD4, a broad-spectrum disinfectant designed for high soil environments of the animal health sector; and Invirtu for skin care. It serves human and animal health, facilities management, food and beverages, household, and skin and pet care markets. The company was incorporated in 2005 and is headquartered in Chester, the United Kingdom.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.K. Market Performance
- 7 Days: 2.0%
- 3 Months: 7.1%
- 1 Year: 13.2%
- Year to Date: 14.5%
The market is up 2.0% over the last week, with the Healthcare sector leading the way, up 10%. The market is up 13% over the last 12 months. Earnings are forecast to grow by 14% annually. Market details ›